Table 2.
Expected number of HIV infections during follow-up | |||
---|---|---|---|
Lower limit of the 95% CI | Median limit of the 95% CI | Upper limit of the 95% CI | |
Parameters from the literature | |||
HIV prevalence among clients of FSW [35] | 0.0134 | 0.032 | 0.0546 |
Per-act transmission risk [30] | 0.0013 | 0.0038 | 0.011 |
Score GUD [26] | 1.3 | 2.58 | 5.69 |
Score HSV-2 infection [26] | 1.7 | 3.1 | 5.6 |
Score HIV stage [26] | |||
Chronic stage | 1 | ||
Primary stage | 2.00 | 4.98 | 12.39 |
Late stage | 1.76 | 3.49 | 6.92 |
Score for detectable viral load [26] | |||
Undetectable | 0.06 | 0.14 | 0.34 |
Detectable | 0.51 | 1.72 | 5.75 |
Estimations | |||
Number of unprotected vaginal sexual acts during follow up with HIV-positive men at: | |||
Primary stage and not taking ART (N1) | 4 | 10 | 16 |
Chronic stage and not taking ART (N 2) | 126 | 295 | 453 |
Chronic stage and taking ART (N3) | 27 | 70 | 171 |
Late stage and not taking ART (N4) | 3 | 8 | 12 |
Late stage and taking ART (N5) | 1 | 2 | 6 |
Number of expected infections during follow-up among FSW n (95% CI) | 0.14 (0.14–0.15) | 5.05 (5.01–5.08) | 42.51 (42.28–42.74) |
pa | 0.86 | 0.005 | <0.001 |
When compared with the 0 observed HIV infection the follow-up.